What are the VA rating percentages for Guillain-Barré Syndrome (Acute Inflammatory Demyelinating Polyneuropathy)?

Guillain-Barré Syndrome (Acute Inflammatory Demyelinating Polyneuropathy) (DC 8011) is rated at 10%, 100% under 38 CFR § 4.124a, DC 8011. Minimum residual rating per § 4.124a DC 8011 framework (by analogy) once the acute febrile phase has resolved.

What happens during a C&P exam for Guillain-Barré Syndrome (Acute Inflammatory Demyelinating Polyneuropathy)?

Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation. Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

← All Condition Guides

CLAIM RECON INTEL

Guillain-Barré Syndrome (Acute Inflammatory Demyelinating Polyneuropathy)

Q: What rates 10% for Guillain-Barré Syndrome (Acute Inflammatory Demyelinating Polyneuropathy) under 38 CFR § 4.124a, DC 8011?

Under 38 CFR § 4.124a, DC 8011 (DC 8011), a 10% rating for Guillain-Barré Syndrome (Acute Inflammatory Demyelinating Polyneuropathy) requires: Minimum residual rating per § 4.124a DC 8011 framework (by analogy) once the acute febrile phase has resolved.

Q: What rates 100% for Guillain-Barré Syndrome (Acute Inflammatory Demyelinating Polyneuropathy) under 38 CFR § 4.124a, DC 8011?

Under 38 CFR § 4.124a, DC 8011 (DC 8011), a 100% rating for Guillain-Barré Syndrome (Acute Inflammatory Demyelinating Polyneuropathy) requires: During the acute phase (active progressive neurological illness, typically with ICU admission, mechanical ventilation, or severe ascending paralysis), GBS is rated 100% by analogy to DC 8011 active febrile disease. After acute resolution and stabilization, rate the residuals — typically peripheral motor or sensory deficits — separately under § 4.124a 8500-8730 by territory, plus any persistent autonomic dysfunction, fatigue, or chronic-pain syndrome, combined under § 4.25.

Q: What evidence do I need for a Guillain-Barré Syndrome (Acute Inflammatory Demyelinating Polyneuropathy) VA claim?

Key evidence for a Guillain-Barré Syndrome (Acute Inflammatory Demyelinating Polyneuropathy) claim includes: Service treatment records showing injury or complaints; Imaging (X-ray, MRI, CT); Range of motion measurements; Flare-up documentation per Sharp v. Shulkin; Buddy statements describing limitations. All evidence should document both the condition and its impact on daily functioning.

DC 801138 C.F.R. § 4.124a

Diagnostic Code

DC 8011

38 C.F.R. § 4.124a

Rating Range

10–100%

2 severity tiers

Source

Verified

38 C.F.R. § 4.124a

Guillain-Barré Syndrome (Acute Inflammatory Demyelinating Polyneuropathy) is rated by the U.S. Department of Veterans Affairs under DC 8011 of 38 CFR § 4.124a, DC 8011 across 2 severity tiers (10% / 100%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.

Educational tool only. Not legal or medical advice. Not affiliated with the VA.

Overview

Acute autoimmune disorder attacking the peripheral nervous system causing rapid-onset muscle weakness and potentially paralysis.

Rating Criteria

10%

Minimum residual rating per § 4.124a DC 8011 framework (by analogy) once the acute febrile phase has resolved.

100%

During the acute phase (active progressive neurological illness, typically with ICU admission, mechanical ventilation, or severe ascending paralysis), GBS is rated 100% by analogy to DC 8011 active febrile disease. After acute resolution and stabilization, rate the residuals — typically peripheral motor or sensory deficits — separately under § 4.124a 8500-8730 by territory, plus any persistent autonomic dysfunction, fatigue, or chronic-pain syndrome, combined under § 4.25.

03Key Evidence

—Service treatment records showing injury or complaints

—Imaging (X-ray, MRI, CT)

—Range of motion measurements

—Flare-up documentation per Sharp v. Shulkin

—Buddy statements describing limitations

—Prescription history

—Physical therapy records

—Employment impact documentation

04C&P Exam Tips

1Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation.

2Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

3Tell the examiner about flare-ups: frequency, duration, estimated ROM loss. Sharp v. Shulkin (2017) requires estimates.

4Request active, passive, weight-bearing, and non-weight-bearing ROM testing per Correia v. McDonald (2016).

5If you use assistive devices (brace, cane), bring them.

6Describe daily activity impact: work, sleep, household tasks.

Tools

Rating Calculator →Secondaries Explorer →C&P Exam Prep →PACT Act Scanner →2026 Rates →

Sources & Editorial

Rating criteria text quoted verbatim from 38 C.F.R. § 4.124a (Neurological conditions and convulsive disorders). Source verified 2026-05-15 by ClaimRecon Editorial Team against the Cornell Law CFR mirror; eCFR.gov is the authoritative government source.

View § 4.124a on eCFR →Cornell Law mirror →Editorial Standards →Suggest a correction →

EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026

LOADING